---
categories: 
- Database
- Release
date: 2021-11-04
title: Database release
---
 Added entries:
- (FDA) _BCR-ABL1_ and sensitivity to asciminib in chronic phase chronic myeloid leukemia. 
- (Clinical evidence) _SPOP_ missense somatic variants and favorable prognosis in de-novo metastatic castration-sensitive prostate cancer. 
- (Clinical evidence) _SPOP_ missense somatic variants and sensitivity to abiraterone in metastatic castration-resistant prostate cancer
- (Clinical evidence) _SPOP_ missense somatic variants and sensitivity to anti-androgen therapy.
- (Inferential) _CD274_ amplification and sensitivity to atezolizumab in non-small cell lung cancer. 

Revised entries:
- (FDA) _FGFR2_ fusions and sensitivity to erdafitnib's description was revised to match the standard's described in our [S.O.P.](https://github.com/vanallenlab/moalmanac-db/blob/main/docs/sop.md).